Survival outcomes of esophageal cancer patients with recurrence after curative treatments

Article Gastroenterology & Hepatology

Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

Yuko Kitagawa et al.

ESOPHAGUS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2

Yuko Kitagawa et al.

ESOPHAGUS (2023)

添加到收藏夹

Article Oncology

The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients

Kotaro Sugawara et al.

Summary: The presence of pretreatment esophageal stenosis significantly affects the survival outcomes of patients with esophageal carcinoma, particularly cancer-specific survival. Even in early-stage disease, patients with stenosis show distinct survival curves. Esophageal stenosis, advanced-stage disease, and non-curative resection are independently associated with poor survival rates.

ANNALS OF SURGICAL ONCOLOGY (2023)

添加到收藏夹

Article Surgery

Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients

Kotaro Sugawara et al.

Summary: This study assessed the prognostic values of various inflammation- and nutrition-based markers in esophageal squamous cell carcinoma (ESCC) patients. It found that certain markers, particularly those derived from CRP, showed predictive capabilities for patient survival outcomes, and these predictive capabilities were enhanced when used in combination with pStage.

WORLD JOURNAL OF SURGERY (2022)

添加到收藏夹

Article Oncology

Selective Lymphadenectomy for Salvage Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma

Shuhei Mayanagi et al.

Summary: This retrospective study compared the outcomes of salvage esophagectomy with selective lymphadenectomy of clinically positive lymph nodes with nonsalvage esophagectomy with 3-field lymphadenectomy. Results showed that dissecting only clinically positive lymph nodes in salvage esophagectomy may lead to good short- and long-term outcomes.

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Surgery

Recurrent Disease After Esophageal Cancer Surgery A Substudy of The Dutch Nationwide Ivory Study

Marianne C. Kalff et al.

Summary: This study investigated the patterns, predictors, and survival of recurrent disease following esophageal cancer surgery. The results showed that nearly half of the patients developed recurrent disease with limited prospects of survival. Higher tumor stage, nonradical resection, and positive lymph node harvest were associated with a higher risk of recurrence.

ANNALS OF SURGERY (2022)

添加到收藏夹

Article Oncology

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy

Ping-Chung Tsai et al.

Summary: This study aimed to evaluate the role of surgical resection in patients with resectable recurrences after curative esophagectomy and to identify their prognostic factors. The study found that mediastinum lymph node recurrence and pathologic T3 stage were associated with worse overall survival (OS) and post-recurrence survival (PRS). No definite survival benefit was noted in patients undergoing surgery for resectable recurrence, except in those without comorbidities.

BMC CANCER (2022)

添加到收藏夹

Article Oncology

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making

Nicolaus Andratschke et al.

LANCET ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Usefulness of Neutrophil to Lymphocyte Ratio at Recurrence for Predicting Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma

Shota Hoshino et al.

Summary: This study showed that the neutrophil to lymphocyte ratio (NLR) at recurrence is a significant predictor of survival in patients with recurrent esophageal cancer. By using a cut-off value of 3.374 determined by survival classification and regression tree (CART) analysis, NLR can facilitate decision making in clinical practice.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Oligometastases After Curative Esophagectomy Are Not One Size Fits All

Tamar B. Nobel et al.

Summary: The presentation and prognosis of esophageal cancer recurrence differ by site, with lung oligometastases showing a more indolent course and potentially benefiting from more aggressive treatment to improve outcomes. This study suggests that a personalized approach to treatment based on the site of recurrence may be beneficial for esophageal cancer patients.

ANNALS OF THORACIC SURGERY (2021)

添加到收藏夹

Article Surgery

Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma

Takeshi Morinaga et al.

Summary: The concept of oligometastasis has gained interest recently. This study focuses on oligometastatic recurrence (OLR) of esophageal squamous cell carcinoma (ESCC) after esophagectomy. OLR was identified in 44% of patients with recurrence and had a significantly better prognosis than the non-OLR group. CLT after recurrence was the only prognostic factor in the OLR group.

SURGERY TODAY (2021)

添加到收藏夹

Article Oncology